Purchase Order HT942525PE047
Award Date 9/25/25
Potential Completion Date 9/24/30
Potential Value $270K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
ABER PROV GRD, MD 21010, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $121,268.59 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The contract, which does not have a set-aside designation, is for FY 2025 base benchmark ultra maintenance services. Roche Diagnostics provides a comprehensive range of laboratory equipment, reagents, test kits, and clinical testing services to federal...
- The Defense Health Agency awarded a $2.21M delivery order to Roche Diagnostics Corporation for chemistry and immunoassay testing services, effective October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract represents a child order under a larger vehicle and carries no set-aside designation, allowing Roche to compete openly in the federal marketplace. The work will be performed at Fort Sam Houston in San Antonio, Texas, a major military medical facility....
- The Defense Health Agency awarded Roche Diagnostics Corporation a $804,117 blanket purchase agreement call contract to provide reagents and peripherals for laboratory testing. The firm fixed price contract was awarded under the agency's indefinite delivery/indefinite quantity diagnostic and laboratory equipment and supplies contract vehicle. Roche will deliver the requested products to support laboratory operations at facilities located in Bethesda, Maryland over an 11-month period of...
- Roche Diagnostics Corporation has been awarded a $100,397.52 firm fixed-price purchase order by the Defense Health Agency for the provision of reportable chemistry analyzers and wet analyzers to support laboratory operations at Langley Air Force Base, Virginia. The contract, awarded on April 15, 2025, carries an ultimate completion date of March 30, 2030, and was made through open competition with no set-aside designation. As a leading manufacturer of in vitro diagnostic solutions and laboratory...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation on April 30, 2025, for a two-month supplies drop shipment with a ceiling value of $138,319.70. This contract represents a firm fixed price arrangement with no set-aside designation, utilizing a pre-existing BPA vehicle rather than a full and open competition. The ultimate completion date is set for June 29, 2026, with the place of performance located in Bethesda, Maryland. As a child...
- Roche Diagnostics Corporation was awarded a federal contract on August 14, 2025, by the Defense Health Agency for COBAS Assembly supplies and services. This is a call order under a Blanket Purchase Agreement with a firm fixed-price structure and a ceiling value of $16,080.07. The work will be performed in Castleton, Indiana, with an ultimate completion date of September 30, 2025. This contract award carries no set-aside designation, indicating open competition in the federal marketplace. The...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, has been awarded a delivery order valued at $722,715.31 by the Defense Health Agency for an Automated Core Lab. The order is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. The work will be performed in Castleton, Indiana, and represents a child contract—indicating it derives from a larger contract vehicle, likely one of Roche's...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
- This is a firm fixed-price purchase order award by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $27,000.00 base year contract is for preventive maintenance and repair services on medical equipment. The award is not set aside for small businesses. Roche Diagnostics holds several significant Indefinite Delivery Vehicle (IDV) contracts and Blanket Purchase Agreements (BPAs)...
- This federal contract award is for molecular testing equipment, with a ceiling value of $247,811.23. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, on July 11, 2025. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a set-aside designation,...